메뉴 건너뛰기




Volumn 14, Issue 2, 2011, Pages 150-154

Survival and prognosticators of gastric cancer that recurs after adjuvant chemotherapy with S-1

Author keywords

Adjuvant chemotherapy; Gastric cancer; Recurrence; S 1

Indexed keywords

CISPLATIN; DOCETAXEL; DOXIFLURIDINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; IRINOTECAN; PACLITAXEL;

EID: 79959372663     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-011-0020-x     Document Type: Article
Times cited : (17)

References (11)
  • 1
    • 0027217474 scopus 로고
    • Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer
    • AM Murad FF Santiago A Petroianu PR Rocha MA Rodrigues M Rausch 1993 Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer Cancer 72 37 41 8508427 10.1002/1097-0142(19930701)72:1<37:: AID-CNCR2820720109>3.0.CO;2-P 1:STN:280:DyaK3s3osVGqtQ%3D%3D (Pubitemid 23182046)
    • (1993) Cancer , vol.72 , Issue.1 , pp. 37-41
    • Murad, A.M.1    Santiago, F.F.2    Petroianu, A.3    Rocha, P.R.S.4    Rodrigues, M.A.G.5    Rausch, M.6
  • 2
    • 71249128928 scopus 로고    scopus 로고
    • Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: A randomised phase 3 study
    • 10.1016/S1470-2045(09)70259-1
    • N Boku S Yamamoto H Fukuda K Shirao T Doi A Sawaki, et al. 2009 Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study Lancet Oncol 10 1027 1028 10.1016/S1470-2045(09)70259-1
    • (2009) Lancet Oncol , vol.10 , pp. 1027-1028
    • Boku, N.1    Yamamoto, S.2    Fukuda, H.3    Shirao, K.4    Doi, T.5    Sawaki, A.6
  • 3
    • 40749153540 scopus 로고    scopus 로고
    • S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): A phase III trial
    • 18282805 10.1016/S1470-2045(08)70035-4 1:CAS:528:DC%2BD1cXivVaqtb4%3D
    • W Koizumi H Narahara T Hara A Takagane T Akiya M Takagi, et al. 2008 S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 215 221 18282805 10.1016/S1470-2045(08)70035-4 1:CAS:528:DC%2BD1cXivVaqtb4%3D
    • (2008) Lancet Oncol , vol.9 , pp. 215-221
    • Koizumi, W.1    Narahara, H.2    Hara, T.3    Takagane, A.4    Akiya, T.5    Takagi, M.6
  • 5
    • 0003192645 scopus 로고    scopus 로고
    • Japanese classification of gastric carcinoma 2nd English edition
    • Japanese Gastric Cancer Association
    • Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma 2nd English edition. Gastric Cancer. 1998;1:10-24.
    • (1998) Gastric Cancer , vol.1 , pp. 10-24
  • 6
    • 55149117787 scopus 로고    scopus 로고
    • Chemotherapy for gastric cancer that recurs after adjuvant chemotherapy with S-1
    • 18820010 10.1093/jjco/hyn096
    • K Shitara K Muro T Ura D Takahari T Yokota A Sawaki, et al. 2008 Chemotherapy for gastric cancer that recurs after adjuvant chemotherapy with S-1 Jpn J Clin Oncol 38 786 789 18820010 10.1093/jjco/hyn096
    • (2008) Jpn J Clin Oncol , vol.38 , pp. 786-789
    • Shitara, K.1    Muro, K.2    Ura, T.3    Takahari, D.4    Yokota, T.5    Sawaki, A.6
  • 7
    • 0034307201 scopus 로고    scopus 로고
    • Pathology and prognosis of gastric carcinoma: Well versus poorly differentiated type
    • 11013353 10.1002/1097-0142(20001001)89:7<1418::AID-CNCR2>3.0.CO;2-A 1:STN:280:DC%2BD3cvmslSlsA%3D%3D
    • Y Adachi K Yasuda M Inomata K Sato N Shiraishi S Kitano 2000 Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type Cancer 89 1418 1424 11013353 10.1002/1097-0142(20001001)89:7<1418::AID- CNCR2>3.0.CO;2-A 1:STN:280:DC%2BD3cvmslSlsA%3D%3D
    • (2000) Cancer , vol.89 , pp. 1418-1424
    • Adachi, Y.1    Yasuda, K.2    Inomata, M.3    Sato, K.4    Shiraishi, N.5    Kitano, S.6
  • 9
    • 2342465869 scopus 로고    scopus 로고
    • A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: A cooperative study group trial (group B)
    • 10097745 1:STN:280:DyaK1M7pslyiug%3D%3D
    • M Mai Y Sakata R Kanamaru M Kurihara M Suminaga J Ota, et al. 1999 A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B) Gan To Kagaku Ryoho 26 487 496 10097745 1:STN:280:DyaK1M7pslyiug%3D%3D
    • (1999) Gan to Kagaku Ryoho , vol.26 , pp. 487-496
    • Mai, M.1    Sakata, Y.2    Kanamaru, R.3    Kurihara, M.4    Suminaga, M.5    Ota, J.6
  • 10
    • 0034830598 scopus 로고    scopus 로고
    • Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions
    • DOI 10.1023/A:1011680507956
    • Y Yamada K Shirao A Ohtsu N Boku I Hyodo H Saitoh, et al. 2001 Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions Ann Oncol 12 1133 1137 11583196 10.1023/A: 1011680507956 1:STN:280:DC%2BD3MrjsFehtQ%3D%3D (Pubitemid 32834495)
    • (2001) Annals of Oncology , vol.12 , Issue.8 , pp. 1133-1137
    • Yamada, Y.1    Shirao, K.2    Ohtsu, A.3    Boku, N.4    Hyodo, I.5    Saitoh, H.6    Miyata, Y.7    Taguchi, T.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.